Navigation Links
Oncolytics Biotech Inc. Transfers 40-Litre cGMP Manufacturing Process for REOLYSIN(R)
Date:5/22/2008

ep organic synthesis of APIs and key intermediates. SAFC has manufacturing facilities around the world dedicated to providing manufacturing services for companies requiring a reliable partner to produce their custom manufactured materials. SAFC has four focus areas - SAFC Pharma, SAFC Supply Solutions(R), SAFC Biosciences(TM), and SAFC Hitech(TM) - and had annual sales of nearly $600 million in 2007. SAFC is one of the world's 10 largest fine chemical businesses. For more information about SAFC, visit http://www.safcglobal.com.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. The Company has customers in life science companies, university and government institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 36 countries and has 7,900 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com.

About Oncolytics Biotech Inc.

Oncolytics is a Calgary-based biotechnology company focused on the development of oncolytic viruses as potential cancer therapeutics. Oncolytics' clinical program includes a variety of Phase I/II and Phase II human trials using REOLYSIN(R), its proprietary formulation of the human reovirus, alone and in combination with radiation or chemotherapy. For further information about Oncolytics, please visit

SOURCE Oncolytics Biotech Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Oncolytics Biotech Inc. Announces Issuance of 27th U.S. Patent
2. Oncolytics Biotech Inc. Collaborators to Present Phase II Sarcoma Trial Results at ASCO Annual Meeting
3. Oncolytics Biotech Inc. Announces U.K. Phase II Clinical Trial Investigating REOLYSIN(R) in Combination with Paclitaxel and Carboplatin
4. Oncolytics Biotech Inc. Starts Patient Enrolment in U.K. Combination REOLYSIN(R)/Cyclophosphamide Trial
5. Oncolytics Biotech Inc. Announces Details of 2008 Annual Shareholder Meeting
6. Oncolytics Biotech Inc. Announces 2008 First Quarter Results
7. Oncolytics Biotech Inc. Announces Journal of Immunology Publication on Reovirus Activation of Dendritic Cells
8. Oncolytics Biotech Inc. Announces Gene Therapy Publication on Reovirus Treatment for Melanoma
9. Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Multiple Myeloma at AACR Annual Meeting
10. Oncolytics Biotech Inc. Collaborators Present Reovirus Research for Pediatric Sarcomas at AACR Annual Meeting
11. Oncolytics Biotech Inc. Completes Dose Escalation in Combination REOLYSIN(R)/Paclitaxel and Carboplatin Trial

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)... , NANJING, China, Dec. 2 /PRNewswire...or the "Company") (NYSE: SCR ), a leading pharma...manufacturing, and marketing of branded,generic an...unced that 105 of,its drugs have been included in ... which was issued by China,s Ministry of Human Res...
(Date:12/2/2009)... The Scientist, a leading sc...ed Photometrics’ Evolve “Intelligent&r...quo;s “Top 10 Innovations of 2009. , ... Evolve ™ EMCCD camera from Photometrics &...nce CCD and EMCCD cameras for the life sciences, w...
(Date:12/1/2009)... , INCLINE VILLAGE, Nev., Dec. 1 /PRNewswire-...PDLI ) today announced revenue guidance for the fo...ely $57 million, as compared with $69 million for ...rter 2008 results was the first of two installment...luded in fourth quarter 2008 results was a one-tim...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Re...h report is available in its catalogue: ,, Eme...arket dynamics and the changing healthcare and reg...r.com/p0165658/Emerging-Clinical-Trial-Locations--...ealthcare-and-regulatory-environment.html ,, O...
Breaking Biology Technology:Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 2The Scientist Names Photometrics' Evolve EMCCD Camera One of the “Top 10 Innovations” of 2009 3PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 2PDL BioPharma Provides Fourth Quarter 2009 Revenue Guidance of Approximately $57 Million 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 2Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 3Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 4Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 5Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 6Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 7Reportlinker Adds Emerging Clinical Trial Locations - Eastern Europe: Market Dynamics and the Changing Healthcare and Regulatory Environment 8
... to create an early healthcare model should be enh...ition of Abbott Laboratories, in-vitro diagnosti...ccording to GE executives. , ,GE and Abbott annou...ement for GE, the parent GE Healthcare, to acquire... units for $8.13 billion in cash. , ,The transacti...
...Wisconsin , in response to the federal government,...a five-year, $8.1 million federal grant to develop...avian flu and the majority of potential bioterrori... National Institutes of Health,s Institute of Alle...lop a device that would be used in outpatient sett...
...elphi Group, a Boston-based consultancy focused on...Perot Systems, Innovation Lab. He will arrive in M...usion 2007 CEO-CIO Symposium . We asked him to sha... information technology professionals can work tog...ideal situation for IT working with business proce...
Other Biology Technology:GE acquisition may boost "early" healthcare strategy 2Medical College lands $8.1M grant to detect bird flu, bioterror agents 2Innovation expert speaks on the business-IT balancing act 2Innovation expert speaks on the business-IT balancing act 3Innovation expert speaks on the business-IT balancing act 4Innovation expert speaks on the business-IT balancing act 5
(Date:12/2/2009)...f, peanut butter, and other foods have done more t...safety. They also are quietly fueling a boom in th...new food safety regulations. That,s the topic of t...hemical & Engineering News , (C&EN) ACS, weekly ne...ley and Senior Correspondent Marc Reisch point out...
(Date:12/2/2009)...ring a cap is good for you, at least if you are a ...s Engineering in Oncology Center have shown that i...bers holds the cell,s nucleus, its genetic storeho... influence on cell and nuclear shape, the research...treatment of diseases such as cancer, muscular dys...
(Date:12/2/2009)...OOD SHORES, Calif. and PALM HARBOR, Fla., Dec. 2 /...e Corporation ("CIC") (OTC Bulletin Board: CICI), ...ns for business process automation in the financia...ic signature verification and Docubase Systems Inc... Document Management (EDM) software provider annou...
Breaking Biology News(10 mins):A cell's 'cap' of bundled fibers could yield clues to disease 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 2CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 3CIC Teams with Docubase Systems to Deliver eSignature Enabled Document Management Solutions 4UCR plant scientists research spawns new discoveries showing how crops survive drought 10793 1UCR plant scientists research spawns new discoveries showing how crops survive drought 10793 2UCR plant scientists research spawns new discoveries showing how crops survive drought 10793 3UCR plant scientists research spawns new discoveries showing how crops survive drought 10793 4ACCSC Grants Catherine Hinds Institute of Esthetics a Distinguished School of Excellence Award Award Recognizes High Level Achievements of Students 61638 1ACCSC Grants Catherine Hinds Institute of Esthetics a Distinguished School of Excellence Award Award Recognizes High Level Achievements of Students 61638 2ACCSC Grants Catherine Hinds Institute of Esthetics a Distinguished School of Excellence Award Award Recognizes High Level Achievements of Students 61638 3Study Shows Hospital Report Cards Unlikely to Spur Improvement 61636 1Study Shows Hospital Report Cards Unlikely to Spur Improvement 61636 2
...nadian and U.S. researchers have made a surprising...cks are surviving in rivers with hydroelectric dam.... , This is the first study of its kind and is c...that includes researchers from the University of B... October 28 issue of the open access journal PLoS...
...his release is available in French . , A McGil...a $100,000 grant from the Gates Foundation to help...rch programs in Botswana and South Africa. , "Pe...stry doesn,t do very much work on diseases of the ... Geary, of McGill,s Institute of Parasitology. "Th...
...WEST LAFAYETTE, Ind. - Earthworms can change the c...est litter and soils, potentially affecting the am...due University researchers. , The Purdue scientis...Institution and Johns Hopkins University, study th... America from Europe. They want to determine the e...
Other Biology News:Similar survival rates for Pacific salmon in Fraser, Columbia Rivers raises new questions 2Boost from McGill, Gates Foundation helps Africans control pharma research 2Earthworm activity can alter forests' carbon-carrying capabilities 2Earthworm activity can alter forests' carbon-carrying capabilities 3
...ly amplify unknown genomic DNA using our patented...dy-to use components, at an extraordinarily compet...d in each kit. The BAC End Amplification kit can b...s such as P1, YAC and BAC, and localized sub-cloni...
Rabbit Anti-Human YV04 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Rabbit Anti-Human YIPF6 Polyclonal Antibody, Unconjugated from Atlas Antibodies
Bovine Calf Serum - 500mL from GeneTex
Biology Products: